0001104659-19-047347.txt : 20190826 0001104659-19-047347.hdr.sgml : 20190826 20190826213434 ACCESSION NUMBER: 0001104659-19-047347 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190821 FILED AS OF DATE: 20190826 DATE AS OF CHANGE: 20190826 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lavino Francesco Maria CENTRAL INDEX KEY: 0001711517 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 191054152 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 4/A 1 a4a.xml 4/A X0306 4/A 2019-08-21 2019-08-21 0 0001641640 Nabriva Therapeutics plc NBRV 0001711517 Lavino Francesco Maria 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406 0 1 0 0 Chief Commercial Officer Ordinary Shares 2019-08-21 4 S 0 3797 2.08 D 11172 D This amendment is being filed solely to correct the transaction code from "F" to "S" for the sale of ordinary shares to satisfy tax withholding obligations in connection with the transaction reported in the Form 4 filed by the reporting person on August 21, 2019. /s/ Robert Crotty, by power of attorney 2019-08-26